Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists

PURPOSE OF REVIEW: Use of gadolinium-based contrast agents (GBCA) in renal impairment is controversial, with physician and patient apprehension in acute kidney injury (AKI), chronic kidney disease (CKD), and dialysis because of concerns regarding nephrogenic systemic fibrosis (NSF). The position tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Schieda, Nicola, Blaichman, Jason I., Costa, Andreu F., Glikstein, Rafael, Hurrell, Casey, James, Matthew, Jabehdar Maralani, Pejman, Shabana, Wael, Tang, An, Tsampalieros, Anne, van der Pol, Christian B., Hiremath, Swapnil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Guideline/Guideline Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024496/
https://www.ncbi.nlm.nih.gov/pubmed/29977584
http://dx.doi.org/10.1177/2054358118778573

Ejemplares similares

Ejemplares similares